CIK 0001649904
- Large accelerated filer
RHYTHM PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- RYTM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 462159271
- Phone
- +1 857-264-4280
- Business address
- 222 BERKELEY STREET, 12TH FLOOR, BOSTON, MA, 02116
- Former names
- RHYTHM METABOLIC, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,753,355
- in 2 filings, $11.8M under 10b5-1 plans
Net −$11,753,355. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-02-01 | Lee Jennifer Kayden EVP, Head of North America | Option exercise | +4,513 | 5,485 | ||
| 2025-02-01 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Restricted Stock Units | −4,513 | 9,024 | ||
| 2025-02-01 | Cramer Pamela J. Chief Human Resources Officer | Option exercise | +2,650 | 16,150 | ||
| 2025-02-01 | Cramer Pamela J. Chief Human Resources Officer | Option exercise · Restricted Stock Units | −2,650 | 5,300 | ||
| 2024-11-11 | Lee Jennifer Kayden EVP, Head of North America | Option exercise 10b5-1 | +20,622 | $6.80 | $140K | 27,474 |
| 2024-11-11 | Lee Jennifer Kayden EVP, Head of North America | Option exercise 10b5-1 | +28,717 | $24.29 | $698K | 56,191 |
| 2024-11-11 | Lee Jennifer Kayden EVP, Head of North America | Option exercise 10b5-1 | +11,642 | $30.66 | $357K | 67,833 |
| 2024-11-11 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −38,051 | $65.68 | $2.5M | 29,782 |
| 2024-11-11 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −17,540 | $66.95 | $1.2M | 12,242 |
| 2024-11-11 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −11,070 | $67.56 | $748K | 1,172 |
| 2024-11-11 | Lee Jennifer Kayden EVP, Head of North America | Sale 10b5-1 | −200 | $68.43 | $14K | 972 |
| 2024-11-11 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,622 | 25,790 | ||
| 2024-11-11 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Stock Option (Right to Buy) 10b5-1 | −28,717 | 71,283 | ||
| 2024-11-11 | Lee Jennifer Kayden EVP, Head of North America | Option exercise · Stock Option (Right to Buy) 10b5-1 | −11,642 | 37,108 | ||
| 2024-11-11 | Shulman Joseph Chief Technical Officer | Option exercise 10b5-1 | +7,969 | $6.80 | $54K | 7,969 |
| 2024-11-11 | Shulman Joseph Chief Technical Officer | Option exercise 10b5-1 | +5,312 | $21.38 | $114K | 13,281 |
| 2024-11-11 | Shulman Joseph Chief Technical Officer | Sale 10b5-1 | −6,604 | $65.73 | $434K | 6,677 |
| 2024-11-11 | Shulman Joseph Chief Technical Officer | Sale 10b5-1 | −5,977 | $67.05 | $401K | 700 |
| 2024-11-11 | Shulman Joseph Chief Technical Officer | Sale 10b5-1 | −700 | $67.83 | $47K | 0 |
| 2024-11-11 | Shulman Joseph Chief Technical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −7,969 | 19,922 |
Page 21 of 36 · 701 trades